J&J consumer brand spinoff Kenvue debuts on NYSE
the new spinoff of Johnson & Johnson's (JNJ) consumer brand segment, debuted on the New York Stock Exchange Thursday at $25.53 per share. That's higher than the upsized pricing of $22 per share J&J announced late Wednesday, along with increased shares of 172.8 million that raised about $3.8…
#johnsonjohnson #jnj #summit #tylenol #motrin #neutrogena #thibautmongon #kenvue #mongon #visioncare